This Plain Language Summary of Publication article (PLSP) from Future Oncology, analyzed medical records from cancer clinics across the U.S. to compare two treatments for people with HR+/HER2– metastatic breast cancer that had spread to the lungs or liver. Researchers looked at whether combining palbociclib with an aromatase inhibitor helped patients live longer compared to using an aromatase inhibitor alone.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice’ and was published in Cancers.

Visit MDPI using the link to read the original article.